Voya Investment Management LLC lowered its position in shares of Genpact Limited (NYSE:G - Free Report) by 13.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 323,864 shares of the business services provider's stock after selling 51,432 shares during the period. Voya Investment Management LLC owned 0.18% of Genpact worth $13,910,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of G. Blue Trust Inc. grew its position in Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after buying an additional 441 shares in the last quarter. Burney Co. lifted its stake in shares of Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after acquiring an additional 92,641 shares during the period. KBC Group NV bought a new position in shares of Genpact in the fourth quarter valued at approximately $298,000. JPMorgan Chase & Co. increased its stake in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the period. Finally, State of New Jersey Common Pension Fund D bought a new stake in Genpact during the fourth quarter worth approximately $2,030,000. Institutional investors and hedge funds own 96.03% of the company's stock.
Insider Buying and Selling
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.80% of the company's stock.
Wall Street Analysts Forecast Growth
G has been the topic of a number of research reports. Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Needham & Company LLC increased their target price on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $50.38.
Read Our Latest Research Report on G
Genpact Stock Up 0.9 %
Shares of Genpact stock traded up $0.43 during midday trading on Friday, hitting $49.67. The company's stock had a trading volume of 1,329,284 shares, compared to its average volume of 1,464,691. The stock has a 50-day simple moving average of $49.40 and a 200-day simple moving average of $46.60. The firm has a market capitalization of $8.73 billion, a P/E ratio of 17.49, a PEG ratio of 1.84 and a beta of 1.06. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.37%. Genpact's dividend payout ratio is currently 23.94%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.